Jenny Deng spoke at the Weijie 2015 ANDA Seminar, June 18-19, 2015, Tianjin, China. The title of her presentation was “Patent Strategies in Generic Drug Development and Approval – Case Studies of ANDA Paragraph IV Challenges.” The conference is a China-US pharmaceutical industry summit designed for Chinese pharmaceutical companies. Ms. Deng covered the following topics: (1) Patent issues under the Hatch Waxman Act, (2) Patent strategies in ANDA drug development and approval, and (3) Case Studies – ANDA Paragraph IV litigations. Other speakers included former U.S. FDA officials and regulatory experts.
Search LIBRARY
Topics
Jenny Deng Spoke at Weijie 2015 ANDA Seminar
18 June 2015

TOPIC TAGS for this article: > Pharma + Biotech > Patents